171 related articles for article (PubMed ID: 12753284)
1. Bone disease in long-term adult kidney transplant patients with normal renal function.
Montalban C; de Francisco AL; Mariñoso ML; Zubimendi JA; García Unzueta M; Amado JA; Arias M
Kidney Int Suppl; 2003 Jun; (85):S129-32. PubMed ID: 12753284
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
3. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
4. Bone disease in patients with long-term renal transplantation and normal renal function.
Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
[TBL] [Abstract][Full Text] [Related]
5. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
[TBL] [Abstract][Full Text] [Related]
7. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
[TBL] [Abstract][Full Text] [Related]
8. Adynamic bone lesion in renal transplant recipients with normal renal function.
Velasquez-Forero F; Mondragón A; Herrero B; Peña JC
Nephrol Dial Transplant; 1996; 11 Suppl 3():58-64. PubMed ID: 8840319
[TBL] [Abstract][Full Text] [Related]
9. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
10. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
12. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
13. Development of lumbar bone mineral density in the late course after kidney transplantation.
Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
[TBL] [Abstract][Full Text] [Related]
15. Alendronate prevents further bone loss in renal transplant recipients.
Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
[TBL] [Abstract][Full Text] [Related]
16. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
17. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
18. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
[TBL] [Abstract][Full Text] [Related]
19. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
Spiechowicz U; Kokot F; Wiecek A
Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
